INS and type 2 diabetes mellitus: It has been reported that SIRT1 activation has a beneficial effect on β-cell function and insulin sensitivity both in animal studies and clinical research (Kitada et al., 2019; Rehman et al., 2020; Zhou et al., 2018), suggesting that SIRT1 may be a promising new target for the treatment of T2DM.